Overview
Canadian Solar Inc., founded in 2001 and headquartered in Ontario, Canada, is a globally prominent company in the renewable energy sector, specifically focusing on the manufacturing of solar photovoltaic modules and the provision of solar energy solutions. The company has a significant presence in both North America and several international markets, engaging in a wide array of projects that range from photovoltaic technology development to large-scale solar systems installations. Canadian Solar is recognized for its innovative developments in solar module technology, which notably include high-efficiency photovoltaic cells and modules. A key venture includes the development of utility-scale solar power projects worldwide, which are pivotal in advancing global sustainability efforts by promoting renewable energy sources. The company's strategic operations also extend into solar system project development, thereby enhancing its portfolio of sustainable energy production capabilities.
AI+ Ask Fintel’s AI assistant about Canadian Solar Inc..
Thinking about good questions…
Basic Stats
The share price of Canadian Solar Inc. as of September 5, 2025 is $11.17 / share. This is an increase of 14.21% from the prior week. The market cap (or net worth) of Canadian Solar Inc. as of September 5, 2025 is $751.60 MM.
The Factor Analysis chart (below right) shows a view of Canadian Solar Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 751.60 MM |
| EV | 6,614.67 MM |
| Shares Out. | 67.17 MM |
| Earnings Date | |
| EPS (TTM) | -0.10 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 10.28 |
| Short Shares Avail. | 0.07 MM |
| Short Interest | 5.24 MM |
| Short Float | 11.48 % |
| Days to Cover | 2.21 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -10.55 % |
| Volatility (1 yr) | 0.84 |
| Beta | 1.15 |
| Sharpe Ratio (1 yr) | -0.18 |
| Sortino Ratio (1 yr) | -0.31 |
| PE Ratio | -108.98 |
| Price/Book | 0.18 |
| Price/TBV | 0.27 |
| Book/Market | 5.56 |
| EBIT/EV | -0.03 |
| EBIT(3yr avg)/EV | 0.03 |
| ROA | -0.00 |
| ROE | -0.00 |
| ROIC | -0.00 |
| CROIC | 0.01 |
| OCROIC | -0.02 |
| Implied Volatility | 71.36 % |
| Put/Call OI Ratio | 0.45 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Canadian Solar Inc. is $12.95. The forecasts range from a low of $7.35 to a high of $22.05. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Canadian Solar Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-23 | GLJ Research | Sell | Maintains | |
| 2022-10-20 | JP Morgan | Neutral | Maintains | |
| 2022-09-08 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2022-08-19 | Goldman Sachs | Neutral | Maintains | |
| 2022-08-08 | JP Morgan | Neutral | Maintains | |
| 2022-07-20 | JP Morgan | Neutral | Maintains | |
| 2022-03-28 | Citigroup | Buy | Maintains | |
| 2021-12-21 | Citigroup | Buy | Maintains | |
| 2021-11-23 | Wells Fargo | Equal-Weight | Initiate | |
| 2021-08-18 | GLJ Research | Buy | Sell | Downgrade |
| 2021-01-08 | Citigroup | Buy | Initiate | |
| 2021-01-05 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2020-11-25 | CICC | Market Perform | Outperform | Upgrade |
| 2020-11-23 | GLJ Research | Buy | Maintains | |
| 2020-08-28 | GLJ Research | Buy | Initiate | |
| 2020-07-29 | JP Morgan | Neutral | Maintains | |
| 2020-05-29 | CFRA | Hold | Buy | Upgrade |
| 2019-11-14 | UBS | Neutral | Maintains | |
| 2019-11-13 | JP Morgan | Neutral | Maintains | |
| 2019-02-11 | UBS | Sell | Neutral | Upgrade |
| 2019-01-03 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2018-10-22 | JP Morgan | Neutral | Underweight | Downgrade |
| 2018-08-23 | B. Riley FBR | Neutral | Neutral | Maintains |
| 2018-06-07 | JP Morgan | Underweight | Neutral | Upgrade |
| 2018-03-27 | JP Morgan | Neutral | Underweight | Downgrade |
| 2018-03-16 | UBS | Sell | Initiate | |
| 2018-02-01 | JP Morgan | Underweight | Neutral | Upgrade |
| 2018-01-09 | Goldman Sachs | Neutral | Initiate | |
| 2017-12-15 | Axiom Capital | Buy | Hold | Downgrade |
| 2017-11-10 | Roth Capital | Neutral | Buy | Upgrade |
| 2017-08-21 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2017-08-16 | FBR Capital | Market Perform | Maintains | |
| 2017-04-17 | Axiom Capital | Buy | Initiate | |
| 2017-02-22 | JP Morgan | Overweight | Neutral | Downgrade |
| 2016-11-23 | Barclays | Equal-Weight | Maintains | |
| 2016-11-22 | Roth Capital | Buy | Neutral | Downgrade |
| 2016-11-22 | FBR Capital | Outperform | Market Perform | Downgrade |
| 2016-09-08 | JMP Securities | Market Perform | Initiate | |
| 2016-08-24 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2016-08-19 | Cowen & Co. | Outperform | Market Perform | Downgrade |
| 2016-08-03 | Morgan Stanley | Overweight | Underweight | Downgrade |
| 2016-04-04 | Barclays | Overweight | Initiate | |
| 2016-03-16 | Northland Securities | Outperform | Initiate | |
| 2016-01-27 | OTR Global | Positive | Mixed | Downgrade |
| 2016-01-21 | Standpoint Research | Hold | Buy | Upgrade |
| 2015-12-18 | FBR Capital | Outperform | Initiate | |
| 2015-11-25 | Standpoint Research | Buy | Hold | Downgrade |
| 2015-11-10 | Morgan Stanley | Overweight | Initiate | |
| 2015-09-24 | Stifel Nicolaus | Buy | Initiate | |
| 2015-09-08 | Oppenheimer | Outperform | Initiate | |
| 2015-08-25 | Cowen & Co. | Outperform | Initiate | |
| 2015-08-21 | Standpoint Research | Hold | Buy | Upgrade |
| 2015-08-19 | Canaccord Genuity | Buy | Maintains | |
| 2015-04-29 | JP Morgan | Overweight | Maintains | |
| 2015-04-07 | Canaccord Genuity | Buy | Maintains | |
| 2015-03-06 | Standpoint Research | Buy | Hold | Downgrade |
| 2015-03-06 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2015-01-13 | CICC | Buy | Initiate | |
| 2014-11-18 | Standpoint Research | Buy | Initiate | |
| 2014-11-18 | JP Morgan | Overweight | Maintains | |
| 2014-10-14 | JP Morgan | Overweight | Maintains | |
| 2014-09-23 | Canaccord Genuity | Buy | Maintains | |
| 2014-09-17 | FBR Capital | Outperform | Maintains | |
| 2014-07-15 | JP Morgan | Overweight | Maintains | |
| 2014-07-07 | FBR Capital | Market Perform | Outperform | Upgrade |
| 2014-07-02 | Canaccord Genuity | Buy | Initiate | |
| 2014-03-11 | Dougherty | Buy | Initiate | |
| 2014-02-19 | JP Morgan | Overweight | Initiate | |
| 2014-02-19 | FBR Capital | Market Perform | Initiate | |
| 2014-01-09 | Nomura | Buy | Maintains | |
| 2013-10-08 | Northland Securities | Outperform | Initiate | |
| 2013-09-20 | Lazard | Buy | Maintains | |
| 2013-08-05 | Roth Capital | Buy | Initiate | |
| 2013-07-12 | Lazard | Neutral | Buy | Upgrade |
| 2013-05-23 | Maxim Group | Buy | Initiate | |
| 2013-01-17 | Nomura | Neutral | Buy | Upgrade |
| 2012-07-12 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2023-01-06 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-02-09 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-05-19 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-05-22 | Goldman Sachs | Sell | Sell | Maintains |
| 2023-05-31 | Roth MKM | Buy | Reiterate | |
| 2023-06-13 | GLJ Research | Sell | Sell | Maintains |
| 2023-08-23 | Roth MKM | Buy | Buy | Maintains |
| 2023-08-23 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2024-05-22 | Roth MKM | Buy | Buy | Maintains |
| 2023-08-29 | UBS | Buy | Buy | Maintains |
| 2024-03-15 | Citigroup | Neutral | Neutral | Maintains |
| 2024-03-15 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2023-07-19 | Citigroup | Neutral | Neutral | Maintains |
| 2023-12-18 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2023-10-18 | Citigroup | Neutral | Neutral | Maintains |
| 2023-08-24 | Citigroup | Neutral | Neutral | Maintains |
| 2023-07-06 | UBS | Neutral | Buy | Upgrade |
| 2023-10-19 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-03-13 | GLJ Research | Sell | Sell | Maintains |
| 2023-11-17 | UBS | Buy | Buy | Maintains |
| 2023-11-15 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-11-15 | JP Morgan | Neutral | Underweight | Downgrade |
| 2024-01-24 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-03-19 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-06-12 | UBS | Buy | Buy | Maintains |
| 2024-07-16 | JP Morgan | Underweight | Underweight | Maintains |
| 2024-08-26 | Roth MKM | Buy | Buy | Maintains |
| 2024-08-26 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-07-30 | GLJ Research | Sell | Sell | Maintains |
| 2025-05-16 | Goldman Sachs | Sell | Sell | Maintains |
| 2024-10-22 | Citigroup | Neutral | Sell | Downgrade |
| 2024-12-13 | Mizuho | Outperform | Initiate | |
| 2024-11-22 | Jefferies | Buy | Initiate | |
| 2024-08-23 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-12-05 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-17 | Citigroup | Sell | Neutral | Upgrade |
| 2025-01-08 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-03-26 | Goldman Sachs | Sell | Sell | Maintains |
| 2025-08-21 | Citigroup | Neutral | Neutral | Maintains |
| 2025-05-19 | Mizuho | Outperform | Outperform | Maintains |
| 2025-05-16 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-22 | Mizuho | Outperform | Outperform | Maintains |
| 2025-06-02 | Mizuho | Outperform | Outperform | Maintains |
| 2025-09-03 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
